GlassScriptPhysician profile
Priscilla Jane Ramsay
NPI 1942253810
$452.10
in general payments reported to CMS, 2019-2025
12 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.74 · 2022: $71.66 · 2023: $115 · 2024: $56.05 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $152.72 | 2021-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $71.57 | 2025 | Caplyta |
| Lilly USA, LLC | $51.12 | 2023-2025 | Mounjaro, Zepbound, Emgality |
| Baxter Healthcare | $40.17 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $29.96 | 2024-2025 | Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $20.36 | 2025 | |
| Lundbeck LLC | $17.32 | 2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $16.98 | 2022 | |
| Photonicare INC | $13.94 | 2025 | Otosight Middle Ear Scope |
| Azurity Pharmaceuticals, INC. | $13.61 | 2025 | Azmiro |
| Paratek Pharmaceuticals, INC. | $12.38 | 2021 | |
| Dexcom, INC. | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Ramsay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.